News regarding prioritization of examination of technologies associated with the treatment and diagnosis of COVID-19

Posted on: 9/4/2020


Considering the pandemic declared by the World Health Organization caused by COVID-19, its impacts on public health and the need for short, medium and long term measures to protect the population from the virus, the Brazilian PTO (INPI) has published on April 7, 2020 a new Resolution No. 149, which refer to the prioritization of examination for patent applications dedicated to pharmaceutical products and processes and equipment and/or materials for use in health, aiming at the diagnosis, prophylaxis and treatment of COVID-19.

The priority procedure, which will take effect until june 30, 2021, will determine the reduction of the time necessary for the decision on the patent application, also being an incentive for the development of new technologies in this area.

  • T. +55 21 3514 0400
  • F. +55 21 3514 0401 / 3852 3495
  • Headquarters: Av. das Américas, 4200, BL9, Suites 217-B to 220-B | Rio de Janeiro, RJ | Brazil | 22640-102.
    São Paulo Branch: 1098, St Leopoldo Couto de Magalhães Júnior / Conj. 44 - Itaim Bibi - São Paulo, SP - CEP 04542-001 Brazil.